Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
站內檢索
:::
:::

 

戴世光 醫師

專長

  • 頭頸部(口腔、咽、喉)腫瘤之診斷與治療
  • 頸部腫塊(甲狀腺、唾液腺腫瘤)之診斷與治療
  • 頭頸部達文西機械手臂微創手術
  • 打鼾及睡呼吸中止症候群之診斷及治療
  • 嗓音異常之診斷及治療

 

耳鼻喉頭頸醫學部  部主任
 

 

門診時間

星期一

上午

線上預約(連結)

星期四

上午
 

 

學經歷

學歷

國立陽明大學醫學院醫學系 醫學士

國立陽明大學醫學院臨床醫學研究所 博士

 

經歷

國立陽明大學醫學院醫學系專任教授兼部主任 –現任

台北榮總耳鼻喉頭頸醫學部喉頸科主任

台灣耳鼻喉頭頸外科醫學會理事

台灣頭頸腫瘤醫學會理事

台灣喉科醫學會理事

美國安德森癌病中心胸腔頭頸腫瘤科研究員

美國安德森癌病中心頭頸外科研究員
 

 

論著

論文

1. Yang CF, Niu DM, Tai SK, Wang TH, Su HT, Huang LY, Soong WJ. (2020) Airway abnormalities in very early treated infantile-onset Pompe disease: A large-scale survey by flexible bronchoscopy. Am J Med Genet A 182(4):721-729.

2. Wu HL, Chu YH, Tai YH, Tsou MY, Wu CH, Lo WL, Tai SK, Yeh CC, Lu CC. (2020) Stage-dependent angiopoietin-Tie2 and nitric oxide signaling of erythrocytes in response to surgical trauma in head and neck cancer. World J Surg Oncol 18(1):209.

3. Huang YW, Wang YP, Lee TL, Chang CF, Hou MC, Tai SK, Chu PY. (2021) Image-enhanced endoscopy for detection of second primary esophageal neoplasms in patients with hypopharyngeal cancer: Prevalence, risk factors, and characteristics. J Chin Med Assoc 84(10):963-968.

4. Ting KC, Lee TL, Li WY, Chang CF, Chu PY, Wang YF, Tai SK*. (2021) Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3-4 oral squamous cell carcinoma. Sci Rep 11(1):19770.

5. Lee TL, Wei PY, Yang MH, Chang PM, Wang LW, Tai SK*. (2022) Tongue conservation treatment for oral tongue squamous cell carcinoma with induction chemotherapy, surgery, and risk-adapted adjuvant therapy: A phase II trial. Cancer Rep (Hoboken) 2022 Feb;5(2):e1456.

6. Lai CL, Chen TH, Chang PM, Tai SK, Chu PY, Yang MH. (2022) Efficacy of cetuximab-containing regimens in the treatment of recurrent/metastatic head and neck cancer after progression to immune checkpoint inhibitors. J Chin Med Assoc 85(6):687-692.

7. Lee TL, Lee YT, Tai SK*. (2022) Neck management in T1-2 early-stage oral squamous cell carcinoma. International Journal of Head and Neck Science 2022;6(2):45-56.

8. Lee TL, Wei PY, Tai SK*. (2022) Effect of local anesthesia on pain scale and specimen adequacy in fine-needle aspiration biopsy of thyroid nodules for liquid-based cytology. Sci Rep 2022 Nov 2;12(1):18498. doi: 10.1038/s41598-022-23031-0.

9. Cheng HY, Hsieh CH, Lin PH, Chen YT, Hsu DS, Tai SK, Chu PY, Yang MH. (2022) Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J Immunother Cancer 2022 Aug;10(8):e004832. doi: 10.1136/jitc-2022-004832.

10. Chen TH, Pan YY, Lee TL, Wang LW, Tai SK, Chu PY, Lo WL, Wu CH, Yang MH, Chang PM. (2022) Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma. BMC Cancer. 2022 Dec 20;22(1):1336. doi: 10.1186/s12885-022-10440-7.

11. Lin TY, Lee TL, Hsu YB, Tai SK, Wang LW, Yang MH, Chu PY. (2023) Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma. Front Oncol. 2023 Mar 3;13:1109417.

12. Chung CH, Lin CY, Chen CY, Hsueh CW, Chang YW, Wang CC, Chu PY, Tai SK, Yang MH. (2023) Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer. Adv Sci (Weinh). 2023 May;10(15):e2204514.

13. Hang JF, Chen JY, Kuo PC, Lai HF, Lee TL, Tai SK, Kuo CS, Chen HS, Li WS, Li CF. (2023) A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases. Mod Pathol. 2023 Sep;36(9):100242.

14. Tsai LY, Chan RW, Shen C, Chen Z, Zhuang P, Chiang YN, Tai SK, Xue K. (2023) A 4-Week Straw Phonation in Water Exercise Program for Aging-Related Vocal Fold Atrophy. J Speech Lang Hear Res. 2023 Aug 3;66(8):2581-2599.

15. Ye YC, Wang YP, Chang TE, Wu PS, Hsin IF, Chen PH, Tai SK, Chu PY, Hou MC, Lu CL. (2024) Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients. Esophagus. 2024 Apr;21(2):131-140.

16. Lee TL, Fang EC, Lee IC, Lirng JF, Chang CF, Hsu YB, Chu PY, Wang YF, Yang MH, Chang PMH, Wang LW, Tai SK. (2024) Enhancing regional control in p16-negative oropharyngeal cancer: A propensity score-matched analysis of upfront neck dissection and definitive chemotherapy. J Chin Med Assoc. 2024 May 1;87(5):516-524.

17. Chou MY, Wu WC, Chu PY, Tai SK, Chang PM, Lee TL, Chen TH, Yang MH. (2024) Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck Cancer. In Vivo. 2024 Jul-Aug;38(4):1891-1899. doi: 10.21873/invivo.13644.

18. Liao TT, Chen YH, Li ZY, Hsiao AC, Huang YL, Hao RX, Tai SK, Chu PY, Shih JW, Kung HJ, Yang MH. (2024) Hypoxia-induced long non-coding RNA HIF1A‑AS2 regulates stability of MHC class I protein in head and neck cancer. Cancer Immunol Res. 2024 Jun 26. doi: 10.1158/2326-6066.CIR-23-0622. Online ahead of print.

 

研究計畫

  1. 戴世光、楊慕華：頭頸鱗狀細胞癌之鐵凋亡與其相關因子GPX4對PD-L1調控之研究。2019/8~2022/7  科技部 MOST 108-2314-B-010-046-MY3
  2. 戴世光、張嘉帆、蔡岳如、王麗美：纖維內視鏡吞嚥評估檢查在頭頸癌應用的優化與驗證研究。2020/1-2020/12  台北榮總 V109C-085
  3. 戴世光、李宗倫、張嘉帆：建立頭頸鱗狀上皮癌人源腫瘤異種移植之研究。2021/1-2021/12 台北榮總 V110C-032 
  4. 戴世光、李宗倫、張嘉帆、高雅娟、蔡岳如、王麗美：經口進食量表在頭頸癌病患纖維內視鏡吞嚥評估檢查的應用研究。2022/1-2022/12  台北榮總V111C-017    
  5. 戴世光、李宗倫、楊慕華：頭頸鱗狀細胞癌之鐵凋亡與細胞焦亡之相互調節研究。2022/8~2025/7  科技部 MOST 111-2314-B-A49-061-MY3  
  6. 戴世光、楊慕華、李宗倫：以加權基因共表現網路分析進行頭頸鱗狀細胞癌空間基因表達研究。2023/1~2023/12  台北榮總V112C-024   
  7. 戴世光、李宗倫、楊慕華：晚期頭頸鱗狀細胞癌前導性化學治療反應的預測分子生物標記之研究。2024/1~2024/12  台北榮總V113C-083  

最後更新：

回到最上